Printer Friendly

A. L. LABORATORIES NAMES JIM FLYNN VICE PRESIDENT, CORPORATE DEVELOPMENT

 FORT LEE, N.J., July 19 /PRNewswire/ -- A. L. Laboratories, Inc. (NYSE: BMD) announced today that James E. Flynn has been named to the newly created position of vice president - corporate development for A. L. Laboratories.
 Mr. Flynn joins the company from Kidder, Peabody & Co. where he was senior vice president - pharmaceutical equity research. His specific focus at Kidder, Peabody was on generic drug, mid-sized branded pharmaceutical, and drug delivery companies.
 Commenting on the appointment, Jeffrey E. Smith, executive vice president of A. L. Laboratories, Inc. said, "Jim Flynn is widely viewed as a leading financial community expert on the generic drug industry and companies specializing in drug delivery. He joins us at a time when economic, regulatory and probable legislative actions have created an environment with exceptional opportunity for us.
 "Mr. Flynn's in depth knowledge of our company combined with his unique perspective on the industry broadens our ability to identify strategic opportunities as we continue to pursue our aggressive growth plans in expanding our position in specialized pharmaceuticals."
 A. L. Laboratories is a multinational manufacturer and marketer of specialized and value-added branded pharmaceuticals and animal health micronutrients, with plant sites in Illinois, Maryland, New Jersey, New York, North Carolina, Washington State, Denmark and Indonesia.
 -0- 7/19/93
 /CONTACT: Iris D. Daniels, investor relations manager of A. L. Laboratories, 201-947-7774; or Donna N. Stein, APR, vice president of Morgen Walke Associates, Inc., 212-850-5600, for A. L. Laboratories/
 (BMD)


CO: A.L. Laboratories, Inc. ST: New Jersey IN: MTC SU: PER

WB -- NY051 -- 3034 07/19/93 12:10 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 19, 1993
Words:261
Previous Article:CHRIS-CRAFT REPORTS HIGHER SECOND QUARTER AND SIX MONTH NET INCOME
Next Article:AMERICAN MEDICAL RESPONSE, INC. APPOINTS ROBERT W. TRINKLEBACK CORPORATE DIRECTOR OF SAFETY AND HEALTH
Topics:


Related Articles
PFIZER NAMES BESSEY HEAD OF U.S. PHARMACEUTICALS; MCKINNELL BECOMES PRESIDENT OF HOSPITAL PRODUCTS
A. L. LABORATORIES ANNOUNCES KEY MANAGEMENT APPOINTMENTS AT ITS BARRE-NATIONAL SUBSIDIARY
NEOSE PHARMACEUTICALS INC. ADDS TWO
A. L. LABORATORIES NAMES BETH POSNACK HECHT AS CORPORATE COUNSEL
PHARMACIA & UPJOHN ANNOUNCES U.S. APPOINTMENTS

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters